| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/19/2011 | CN101952259A Benzodiazepine compound and pharmaceutical composition |
| 01/19/2011 | CN101951773A Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4] nonane and novel salt forms of the racemate and enantiomers |
| 01/19/2011 | CN101948472A Novel staurosporine analogue and preparation method and applications thereof |
| 01/19/2011 | CN101948425A Compound as glucocorticoid ligand, pharmaceutical composition including same, kit and method for preparing same |
| 01/19/2011 | CN101560213B Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application |
| 01/18/2011 | US7872126 Tetrahydroquinoline derivatives and a process for preparing the same |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | CA2573219C Hepatitis c inhibitor dipeptide analogs |
| 01/18/2011 | CA2500964C Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 01/18/2011 | CA2432148C Tri-heterocyclic compounds and a pharmaceutical comprising them as an active ingredient |
| 01/13/2011 | WO2011005295A1 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto |
| 01/13/2011 | US20110009628 Compounds and Compositions for Modulating Lipid Levels and Methods of Preparing Same |
| 01/13/2011 | US20110009626 Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 01/13/2011 | US20110009443 Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009399 Organic compounds |
| 01/13/2011 | US20110009394 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 01/13/2011 | US20110009392 Gamma secretase modulators |
| 01/13/2011 | US20110009391 Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| 01/13/2011 | US20110009388 Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine |
| 01/13/2011 | US20110009386 Furo[3, 2-b] pyrr0l-3-0nes as cathespin s inhibitors |
| 01/13/2011 | US20110009385 Compounds |
| 01/13/2011 | US20110009367 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/13/2011 | US20110009366 Bicyclic pyrimidinones and uses thereof |
| 01/13/2011 | US20110008461 Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase |
| 01/12/2011 | EP2272840A1 Intermediate compound for the preparation of halichondrin analogs |
| 01/12/2011 | EP2272839A1 Intermediate compounds for the preparation of halichondrin analogs |
| 01/12/2011 | EP2271649A1 Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-a]pyrimidines, methods for preparation and uses thereof |
| 01/12/2011 | EP1682138B1 Heterocyclic inhibitors of mek |
| 01/12/2011 | CN101941977A Antitumoral analogs of lamellarins |
| 01/12/2011 | CN101941976A Process for preparing erythricine from gentian |
| 01/12/2011 | CN101029022B Process for the preparation of 4-phenoxy quinoline derivatives |
| 01/11/2011 | US7868172 2-(hetero)-aryl substituted tetrahydroquinoline derivatives |
| 01/11/2011 | US7868018 such as N [3-(2-(3-trifluoromethyl)-benzoylamino -[1,6]naphthyridin-3-yl)-2,4-dichloro-phenyl]-3-trifluoromethyl-benzamide, used as antiproliferative agents or for the treatment of autoimmune diseases and nervous system disorders |
| 01/11/2011 | US7868000 Aspartyl protease inhibitors |
| 01/11/2011 | CA2503371C Quinazoline derivatives as src tyrosine kinase inhibitors |
| 01/11/2011 | CA2468824C Hexacyclic compounds |
| 01/11/2011 | CA2430124C Lactam compounds and pharmaceutical use thereof |
| 01/11/2011 | CA2422054C Bicyclic heteroaromatic compounds |
| 01/11/2011 | CA2407593C Fused heteroaryl derivatives |
| 01/11/2011 | CA2372063C Pyridopyranoazepine derivatives, their preparation and their therapeutic application |
| 01/06/2011 | WO2011002708A1 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 01/06/2011 | WO2011002067A1 Heterocyclic compound and use thereof |
| 01/06/2011 | WO2011000217A1 Synthetic method of key intermediate for preparation of camptothecin-like compounds |
| 01/06/2011 | US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
| 01/06/2011 | US20110003788 Fused heterocyclic derivative and use thereof |
| 01/06/2011 | US20110003776 Tetrahydropyranonaphthyridines derivatives, pharmaceutical compositions and therapeutic treatment thereof |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002886 Tetrahydrofuro [3,4-d] dioxolane compounds for use in the treatment of viral infections and cancer |
| 01/06/2011 | CA2764878A1 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 01/05/2011 | EP2270101A1 Synthetic resin composition, and automotive interior/exterior material comprising the same |
| 01/05/2011 | EP2268643A1 Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors |
| 01/05/2011 | EP2268618A1 Compounds and compositions as tlr activity modulators |
| 01/05/2011 | CN101939312A Gamma secretase modulators |
| 01/05/2011 | CN101939296A Carbazole-containing materials in phosphorescent light emitting diodes |
| 01/05/2011 | CN101362766B Extraction method for preparing high-purity allocryptopine |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863427 labeling haptens, immunogens |
| 01/04/2011 | US7863306 Broadspectrum 2-amino-benzoxazole sulfonamide HIV protease inhibitors |
| 01/04/2011 | US7863288 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents |
| 01/04/2011 | CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie |
| 01/04/2011 | CA2543722C Tocopherol-modified therapeutic drug compounds |
| 01/04/2011 | CA2505555C Spirocyclic cyclohexane derivatives |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2375008C Phenoxypropylamine compounds |
| 12/30/2010 | US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 12/30/2010 | US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 12/30/2010 | US20100331324 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 12/30/2010 | US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors |
| 12/30/2010 | US20100331305 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use |
| 12/30/2010 | US20100330685 Diaminorhodamine derivative |
| 12/30/2010 | US20100330009 Coumestan-like antioxidants and uv absorbants |
| 12/30/2010 | US20100329978 Highly selective sigma receptor ligands |
| 12/29/2010 | WO2010150905A1 Chromene compound |
| 12/29/2010 | WO2010150281A2 Novel azabicyclohexanes |
| 12/29/2010 | WO2010150255A1 Conjugates of cytotoxic drugs |
| 12/29/2010 | WO2010149944A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 12/29/2010 | WO2010149943A1 New compounds and medical use |
| 12/29/2010 | WO2010149326A1 Acid-labile trigger units |
| 12/29/2010 | EP2266988A1 [3.2.0] Heterocyclic compounds and methods of using the same |
| 12/29/2010 | EP2266964A1 Acid-labile trigger units |
| 12/29/2010 | EP2265620A1 Spiro derivatives of parthenin as novel anticancer agents |
| 12/29/2010 | EP2265616A1 Furo-and thieno[3,2-c]pyridines |
| 12/29/2010 | EP2265607A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 12/29/2010 | EP2265589A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 12/29/2010 | EP2265275A2 Antiviral therapeutic agents |
| 12/29/2010 | EP2265270A1 2-aminopyridine kinase inhibitors |
| 12/29/2010 | CN1902196B Thiazole derivative |
| 12/29/2010 | CN101932585A Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands |
| 12/29/2010 | CN101928264A Apoptosis promoters |
| 12/29/2010 | CN101323618B Method for separating and preparation of Gelsemium elegans alkaloid monomer by high speed counter current chromatography |
| 12/29/2010 | CA2803330A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer |
| 12/29/2010 | CA2766320A1 Acid-labile trigger units |
| 12/29/2010 | CA2766291A1 Injectable formulations containing asenapine and method of treatment using same |
| 12/29/2010 | CA2766151A1 Oxo-heterocycle fused pyrimidine compounds, compositions and methods of use |
| 12/29/2010 | CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity |
| 12/29/2010 | CA2765692A1 Novel azabicyclohexanes |
| 12/28/2010 | US7858627 Topoisomerase-targeting agents |
| 12/23/2010 | WO2010148138A2 Camptothecin derivatives |